Results 11 to 20 of about 53,364 (321)

Preparation, optimization, and evaluation of midazolam nanosuspension: enhanced bioavailability for buccal administration. [PDF]

Prog Biomater, 2021
Soroushnia A, Ganji F, Vasheghani-Farahani E, Mobedi H.   +3 more
europepmc   +3 more sources

Case Report: Buccal administration of hydrogen-producing blend after a mild traumatic brain injury in a professional athlete. [PDF]

F1000Res, 2019
Javorac D, Stajer V, Ostojic SM.
europepmc   +3 more sources

Preformulation Studies of Furosemide-Loaded Electrospun Nanofibrous Systems for Buccal Administration. [PDF]

Polymers (Basel), 2017
Kovács A, Démuth B, Meskó A, Zelkó R.   +3 more
europepmc   +3 more sources

Hypoglycemic Effect of Pleurotus citrinopileatus and Hericium erinaceus Buccal Tablets on Diabetic Mice [PDF]

Biology
Diabetes mellitus poses a global health challenge, necessitating natural adjuvants with minimal side effects. The aims of this study were to optimize the concentrations of chromium (Cr), zinc (Zn), and germanium (Ge) in the liquid fermentation media of ...
Zhongyi Yang, Kailu Zhang, Yan Liang, Kexin Shi, Jinqiang Ma, Juan Yu, Cunlong Lu, Aimin Liu, Xiancan Zhu   +8 more
doaj   +2 more sources

Development and evaluation of a composite dosage form containing desmopressin acetate for buccal administration. [PDF]

Int J Pharm X, 2021
Kottke D, Burckhardt BB, Knaab TC, Breitkreutz J, Fischer B.   +4 more
europepmc   +2 more sources

Stability of Oxandrolone in Medium-Chain Triglyceride Oil and Pharmacokinetics Following Buccal Administration of the Extemporaneous Formulation in Neonates and Adults. [PDF]

J Pediatr Pharmacol Ther, 2020
Linakis MW, Rower JE, Sorenson S, Reilly CA, Lambert LM, Williams RV, Burch PT.   +6 more
europepmc   +3 more sources

Buccal Administration of a Zika Virus Vaccine Utilizing 3D-Printed Oral Dissolving Films in a Mouse Model. [PDF]

Vaccines (Basel)
Shah S, Patel P, Ferguson A, Bagwe P, Kale A, Adediran E, Singh R, Arte T, Pasupuleti D, Uddin MN, D'Souza M.   +10 more
europepmc   +3 more sources

Assessing efficacy and safety of buccally inoculated midazolam and intravenously administered diazepam for relieving pediatric primary generalized epileptic seizures

Эпилепсия и пароксизмальные состояния, 2021
Objective: to confirm a therapeutic equivalence and similar safety profile of “Midazolam, oromucosal (buccal) solution” and “Sibazon, solution for intravenous and intramuscular administration” used in children aged from 1 year to 18 years suffering from ...
A. G. Prityko, K. V. Osipova, P. L. Sokolov, E. A. Ezhova, I. G. Kotel’nikova, E. G. Lukyanova, G. A. Osipova   +6 more
doaj   +1 more source

New Technological Approaches for Dental Caries Treatment: From Liquid Crystalline Systems to Nanocarriers

Pharmaceutics, 2023
Dental caries is the most common oral disease, with high prevalence rates in adolescents and low-income and lower-middle-income countries. This disease originates from acid production by bacteria, leading to demineralization of the dental enamel and the ...
Marcela Tavares Luiz, Leonardo Delello di Filippo, Jessyca Aparecida Paes Dutra, Juliana Santos Rosa Viegas, Amanda Letícia Polli Silvestre, Caroline Anselmi, Jonatas Lobato Duarte, Giovana Maria Fioramonti Calixto, Marlus Chorilli   +8 more
doaj   +1 more source

Significant hypotension following buccal midazolam administration [PDF]

BMJ Case Reports, 2010
Buccal midazolam is a rescue medication to reduce the duration of or stop an epileptic seizure, and is used to prevent status epilepticus. It is available in various forms, including a buccal preparation with a strength of 10 mg/1 ml. Midazolam is a licensed medication, but the buccal formulation is currently used off-licence.
Maria, Kensche, Josemir W, Sander, Sanjay M, Sisodiya   +2 more
openaire   +2 more sources